Effectiveness of rotavirus vaccine against rotavirus-coded hospitalisations among Australian Aboriginal and non-Aboriginal children

Thomas Snelling, Parveen Fathima

Research output: Contribution to conferenceAbstract

Abstract

Introduction Rotavirus vaccine, RV1 (Rotarix), was included in the immunisation programs in Western Australia (WA) and New South Wales from mid-2007. In WA, RV1 was replaced with RV5 (RotaTeq) in mid-2009. Marked declines in rotavirus-related hospitalisations in both Aboriginal and non-Aboriginal children have been demonstrated following the implementation of the program. Objectives and Approach We aimed to assess RV1 vaccine effectiveness (VE) against rotavirus-coded hospitalisations among Aboriginal and non-Aboriginal children aged (1-hazard ratio*100) were obtained from Cox proportional hazards models (adjusted for infant, maternal and demographic factors and stratified by state of birth) for Aboriginal and non-Aboriginal children. Results There were a total of 623 rotavirus-coded hospitalisations among the cohort children aged <2 years. Rotavirus hospitalisation rates were 143.0/100,000 child-years (95% confidence interval [CI]: 113.3-180.4) among Aboriginal children and 49.0/100,000 child-years (95% CI: 44.8-53.5) among non-Aboriginal children. Compared to unvaccinated children, 1-dose VE among Aboriginal children against rotavirus-coded hospitalisations was 52.1% (95% CI: -0.02-77.1%) and 2-dose VE was 62.4% (95% CI: 26.9-80.7%) adjusting for birthweight, region of residence, socio-economic status, and year of birth. Among non-Aboriginal children, 1-dose VE was 39.0% (95% CI: 13.1-57.2%) and 2-dose VE was 53.4% (95% CI: 38.1-65.1%) adjusting for birth weight, mode of delivery and maternal age at birth and year of birth. Conclusion/Implications Burden of rotavirus gastroenteritis remains significant in Aboriginal children. Given the previously demonstrated declines in rotavirus-related hospitalisations in this population following vaccine introduction, our lower-than-expected VE estimates might represent bias introduced by differences in health-seeking behaviour between the vaccinated and unvaccinated, herd immunity and/or possible non-differential misclassification of the outcome.
Original languageEnglish
DOIs
Publication statusPublished - 20 Aug 2018
EventInternational Population Data Linkage Conference - Banff Centre, Banff, Alberta, Canada
Duration: 12 Sep 201814 Sep 2018
https://ijpds.org/issue/view/9

Conference

ConferenceInternational Population Data Linkage Conference
Abbreviated titleIPDLN
CountryCanada
CityBanff, Alberta
Period12/09/1814/09/18
Internet address

Fingerprint Dive into the research topics of 'Effectiveness of rotavirus vaccine against rotavirus-coded hospitalisations among Australian Aboriginal and non-Aboriginal children'. Together they form a unique fingerprint.

Cite this